Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Hikma Pharmaceuticals (HIKL)

Add To Portfolio

1,613.50p

Change Today:

-7.50p
52 Week High: 2,348.00
52 Week Low: 1,610.00

Currency: UK Pounds
Shares Issued: 199.39m
Volume: 8,721

Market Cap: £3,217.08m

HIKL Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO:	Riad Mishlawi
Executive Chairman:	Said Darwazah
Executive Vice Chairman:	Mazen Darwazah
Independent Non-Executive Director:	Laura Balan Balan
Independent Non-Executive Director:	Mary (Nina) Henderson
Independent Non-Executive Director:	Cynthia Schwalm
Independent Non-Executive Director:	Deneen Vojta
Independent Non-Executive Director:	Douglas Hurt
Senior Independent Director:	Victoria Hull
Non-Executive Dir:	Ali Al-Husry

Contact Details

Address:	1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone:	+44 (0)20 7399 2760
Fax:	+44 (0)20 7399 2761
Website:	http://www.hikma.com

Listings

Overseas Listings:	LSE:HIK
ISIN:	GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

HIKL Market Data

Currency	UK Pounds
Share Price	1,613.50p
Change Today	-7.50p
% Change	-0.46 %
52 Week High	2,348.00
52 Week Low	1,610.00
Volume	8,721
Shares Issued	199.39m
Market Cap	£3,217.08m